ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0932

Compartment-specific NK-cell phenotypes reveal distinct maturation and activation states in inflammatory arthritis

Franca Sophie Deicher1, Tarik Exner2, Maren Claus3, Schayan Yousefian4, Lea Rodon5, sophie leonhardt6, Jörg Distler7, Carsten Watzl3, Hanns-Martin Lorenz8, Simon Haas4, Daniel Hübschmann9 and Wolfgang Merkt10, 1Uniklinik Düsseldorf, Düsseldorf, Germany, 2University Hospital Heidelberg, Heidelberg, Germany, 3IfADo, Leibniz Institute Dortmund, Dortmund, Germany, 4Charite, Berlin, Berlin, Germany, 5University Hospital Heidelberg, Heidelberg, Hungary, 6Heidelberg University, Heidelberg, Germany, 7University Hospital Duesseldorf and HHU, Duesseldorf, Germany, 8Universitétsklinikum Heidelberg, Heidelberg, Germany, 9Heidelberg University, Berlin, Germany, 10University Hospital Düsseldorf, Düsseldorf, Germany

Meeting: ACR Convergence 2025

Keywords: innate immunity, Innate Immunity Rheumatic Disease, Natural Killer Cells, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Synovial natural killer (NK) cells contribute to inflammation in arthritis by secreting cytokines and modulating synovial fibroblast activation. The aim of this study is to describe systemic versus local inflammatory changes of NK-cell subsets as well as their physical cell-cell interactions in arthritis patients.

Methods: Spectral flow cytometry was used to compare paired peripheral blood (PB) and synovial fluid (SF) immune cells from patients with active inflammatory arthritis and healthy controls. Physical cell-cell interactions within tissues were studied by applying a recently developed cellular interaction mapping framework Interact-omics (Vonficht et al., 2025, accepted in Nature Methods).

Results: Our paired approach revealed significant local enrichment of immature and activated NK-cells in SF, characterized by elevated markers of early differentiation, immune checkpoint regulation, and tissue residency, highlighting tightly controlled immune activation at inflamed sites. Single-cell analysis confirmed heterogeneity within SF-NK-cells, suggesting multiple co-existing activation states and developmental stages. PB-NK-cells from patients differed profoundly from healthy controls, showing less immature NK-cell subsets and an enrichment of mature, pro-inflammatory subsets indicative of systemic immune activation. Cellular interaction mapping revealed mainly NK/neutrophil interactions of patients’ NK-cells, while interactions with B-cells, T-cells or monocytes were negligible. T-cells also displayed profound local and systemic alterations. Cellular interaction mapping revealed that next to NK-cell/neutrophil interactions, interactions between B-cells with monocytes and T-cells with neutrophils characterize joint inflammation.

Conclusion: This paired high-dimensional analysis revealed systemic and local alterations in NK-cell subsets shaped by co-existing developmental stages and immune regulatory mechanisms. Cellular interaction mapping indicated that neutrophils are a main interaction partner of NK-cells in inflamed joints.

Supporting image 1NK cells display phenotypic changes in peripheral blood and synovial fluid in patients with inflammatory arthritis. A Graphical experimental design. B Cell frequencies. Frequencies of the indicated cell types were plotted as a percentage of PBMC. C Sample correlation analysis on a pseudobulk level. NK cells were correlated as described in the methods section. Hierarchical clustering revealed three subgroups which correspond to cells of different tissue and patient group (healthy and inflammatory arthritis). D Sample-wise principal component analysis. Samples were grouped by PCA and colored by tissue and patient group (left) and the metaclusters (right) as calculated in C. E Differential expression analysis. Fold-changes (x-axis, asinh_fc) were calculated as described in the Methods section. Notably, NK cells analyzed from peripheral blood show significant phenotypic differences comparing healthy controls and patients with inflammatory arthritis, including expression changes of CD161, KLRG1, PD-1 and CD56. Comparison of NK cells extracted from peripheral blood and synovial fluid show a differential phenotype with the elevation of activation markers such as NKG2A and CD69 and the corresponding downregulation of CD16 and CD57. PB: peripheral blood, SF: synovial fluid. P-values were calculated as described in the methods section where p-values above 0.05 were considered not significant (n.s.).


Disclosures: F. Deicher: None; T. Exner: None; M. Claus: None; S. Yousefian: None; L. Rodon: None; s. leonhardt: None; J. Distler: 4D Science, 8, 11, Actelion, 2, 6, Active Biotech, 2, 6, Anamar, 2, 6, Array Biopharma, 2, 6, ARXX Therapeutics, 2, 6, aTyr Pharma, 2, 6, Bayer Pharma, 2, 6, BMS (Bristol-Myers Squibb), 2, 6, Boehringer Ingelheim, 2, 6, Celgene, 2, 6, FibroCure, 4, Galapagos, 2, 6, GSK, 2, 6, Inventiva, 2, 6, JB Therapeutics, 2, 6, Medac, 2, 6, Novartis, 2, 6, Pfizer, 2, 6, Redx Pharma, 2, 6, RuiYi, 2, 6, Sanofi-Aventis, 2, 6, UCB, 2, 6; C. Watzl: None; H. Lorenz: None; S. Haas: None; D. Hübschmann: None; W. Merkt: Boehringer-Ingelheim, 6, Bristol-Myers Squibb(BMS), 5, Evotec, 5, Glapagos, 12, support for congress travel, Kyverna, 6, Lilly, 12, support for congress travel.

To cite this abstract in AMA style:

Deicher F, Exner T, Claus M, Yousefian S, Rodon L, leonhardt s, Distler J, Watzl C, Lorenz H, Haas S, Hübschmann D, Merkt W. Compartment-specific NK-cell phenotypes reveal distinct maturation and activation states in inflammatory arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/compartment-specific-nk-cell-phenotypes-reveal-distinct-maturation-and-activation-states-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/compartment-specific-nk-cell-phenotypes-reveal-distinct-maturation-and-activation-states-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology